Pharmaceutical science and technology company ‘Zhongsheng Quantai’ received a series A financing of ¥100 million led by Boyi Fund

Pharmaceutical science and technology company “zhongsheng Quantai” completed ¥100 million of A round of financing led by Boyi Fund and followed by Xingxiang Capital. This round of financing will mainly be used for the construction of the company’s hexapeptide library, the optimization of new peptide drug screening platform, and the development of self-developed new drugs.

Founded in 2017, Zhongsheng Quantai is a platform enterprise focusing on the discovery of leading peptide drugs, aims at the R&D, production, and sales of large capacity peptide library and technical services of new peptide drug screening and development.